Search Results - Zehngebot, LM

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles of docetaxel and carboplatin with trastuzumab and/or lapatinib in patients with HER2+ breast cancer (TRIO-US B07)

    Abstract S1-02: Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles... by Hurvitz, SA, Miller, JM, Dichmann, R, Perez, AT, Patel, R, Zehngebot, LM, Allen, H, Bosserman, LD, DiCarlo, BA, Kennedy, A, Giuliano, A, Calfa, CJ, Molthrop, DC, Mani, A, Dering, J, Wang, H-J, Adams, B, Martinez, D, Chen, H-W, Zoeller, J, Brugge, JS, Slamon, DJ

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P1-11-12: Phase II Trial of Presurgical Treatment with Trastuzumab (H) or Lapatinib (Ty) or the Combination of Trastuzumab and Lapatinib (H+Ty), Followed by Six Cycles of Docetaxel (T) and Carboplatin (C) with Trastuzumab (TCH) or Lapatinib (TCTy) or the Combination of Trastuzumab and Lapatinib (TCHTy) in Patients with HER2+ Breast Cancer

    Abstract P1-11-12: Phase II Trial of Presurgical Treatment with Trastuzumab (H) or Lapatinib (Ty) or the Combination of Trastuzumab and Lapatinib (H+Ty), Followed by Six Cycles of... by Callahan, RD, Patel, R, Chan, D, Allison, MA, DiCarlo, B, Bosserman, LD, Kennedy, A, Zehngebot, LM, Miller, J, Giuliano, AE, Spivack, B, Lin, L-s, Slamon, DJ, Hurvitz, SA

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes

    HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes by Guerry, 4th, D, Alexander, M A, Herlyn, M F, Zehngebot, L M, Mitchell, K F, Zmijewski, C M, Lusk, E J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Functional consequence of variation in melanoma antigen expression

    Functional consequence of variation in melanoma antigen expression by ZEHNGEBOT, L. M, ALEXANDER, M. A, GUERRY, D. IV, CINES, D. B, MITCHELL, K, HERLYN, M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: